Table 2. The recurrence risk of NMIBC during the follow-up period.
| WLI | NBI | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Author/year | Patients, n | Operation method | 3-mo RR, n | 1-yr RR, n | 2-yr RR, n | Total patients, n | Operation method | 3-mo RR, n | 1-yr RR, n | 2-yr RR, n | Total patients, n |
| Angelo Naselli/2012 | 148 | ETUR | 12 | 37 | 72 | ETUR | 3 | 24 | 76 | ||
| Harry W. Herr/2014 | 254 | ETUR | 30 | 42 | 127 | ETUR | 14 | 28 | 127 | ||
| Kohei Kobatake/2015 | 135 | ETUR | 3 | 31 | 78 | ETUR | 2 | 12 | 57 | ||
| Stănescu F/2014 | 260 | ETUR | 17 | 24 | 97 | BPV | 7 | 11 | 93 | ||
| Bogdan Geavlete/2011 | 220 | ETUR | 6 | 16 | 90 | BPV | 2 | 7 | 89 | ||
| Ma Tianji/2015 | 209 | ETUR | 17 | 35 | 92 | HLR | 5 | 16 | 86 | ||
| Total | 1226 | TUR | Total RR,n: 185 | 556 | TUR | Total RR,n: 98 | 528 | ||||